|
|
Volumn 31, Issue 9, 2013, Pages 771-773
|
|
Doubts raised over 'read-through' Duchenne drug mechanism.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATALUREN;
OXADIAZOLE DERIVATIVE;
DRUG INDUSTRY;
HUMAN;
MUSCULAR DYSTROPHY, DUCHENNE;
DRUG INDUSTRY;
HUMANS;
MUSCULAR DYSTROPHY, DUCHENNE;
OXADIAZOLES;
|
|
EID: 84899470446
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0913-771 Document Type: Note |
|
Times cited : (10)
|
|
References (0)
|
